Christopher J. Yuskaitis, Ph.D.
Affiliations: | 2009 | Cell Biology | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Neuroscience BiologyGoogle:
"Christopher Yuskaitis"Parents
Sign in to add mentor| Richard S. Jope | grad student | 2009 | UAB | |
| (Neuroinflammation and Fragile X syndrome: Regulation by glycogen synthase kinase-3.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yuskaitis CJ, Rossitto LA, Gurnani S, et al. (2019) Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice. Human Molecular Genetics |
| Trowbridge SK, Yuskaitis CJ, Baumer N, et al. (2019) Brain MRI abnormalities in patients with infantile spasms and Down syndrome. Epilepsy & Behavior : E&B. 92: 57-60 |
| Yuskaitis CJ, Jones BM, Wolfson RL, et al. (2017) A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility. Neurobiology of Disease |
| Winden KD, Yuskaitis CJ, Poduri A. (2015) Megalencephaly and Macrocephaly. Seminars in Neurology. 35: 277-87 |
| Poduri A, Heinzen EL, Chitsazzadeh V, et al. (2013) SLC25A22 is a novel gene for migrating partial seizures in infancy. Annals of Neurology. 74: 873-82 |
| Yuskaitis CJ, Beurel E, Jope RS. (2010) Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochimica Et Biophysica Acta. 1802: 1006-12 |
| Mines MA, Yuskaitis CJ, King MK, et al. (2010) GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. Plos One. 5: e9706 |
| Yuskaitis CJ, Mines MA, King MK, et al. (2010) Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochemical Pharmacology. 79: 632-46 |
| Yuskaitis CJ, Jope RS. (2009) Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cellular Signalling. 21: 264-73 |
| Min WW, Yuskaitis CJ, Yan Q, et al. (2009) Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential. Neuropharmacology. 56: 463-72 |